H.B. Fuller beats Q2 estimates; raises full-year midpoint outlook

H.B. Fuller

24/06/2026 21:20

Overview
Adhesives maker's fiscal Q2 net revenue rose 5.8%, beating analyst expectations
Adjusted EPS for fiscal Q2 increased 19% and beat analyst expectations
Company repurchased 750,000 shares and raised midpoint of full-year guidance

Outlook
H.B. Fuller raises midpoint of full-year adjusted EBITDA guidance to $650 mln-$675 mln
Company lifts midpoint of full-year adjusted EPS guidance to $4.60-$4.90
H.B. Fuller expects Q3 adjusted EBITDA of $180 mln-$190 mln

Result Drivers
PRICING EXECUTION - Co said pricing actions increased net revenue and drove margin improvement
RESTRUCTURING SAVINGS - Co said restructuring initiatives contributed to higher gross margin and adjusted EBITDA
FOREIGN CURRENCY - Co said foreign currency translation contributed 3.1% to net revenue growth

Company press release: ID:nBw8Jl01ba

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$950 mln
$924.79 mln (7 Analysts)
Q2 Adjusted EPS
Beat
$1.41
$1.40 (7 Analysts)
Q2 Adjusted Net Income
Beat
$78 mln
$76.76 mln (6 Analysts)

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for H.B. Fuller Company is $72.00, about 14.1% above its June 23 closing price of $63.12
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 14 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)